The Surgeon Showdown: DeBakey vs. Cooley and the Race That Changed HeartSurgery Forever

In the gleaming corridors of Houston’s Texas Medical Center during the 1960s, two men were rewriting the rules of what was medically possible. They worked mere blocks apart, operated on the most hopeless cardiac cases, and pushed the boundaries of heart surgery further than anyone thought achievable. They were also locked in one of medicine’s most bitter rivalries—a feud so intense they wouldn’t speak to each other for nearly four decades.
Dr. Michael DeBakey and Dr. Denton Cooley weren’t just good surgeons. They were virtuosos who transformed cardiovascular surgery from a desperate gamble into a legitimate field of medicine. Their competition drove innovation at a blistering pace, saved countless lives, and put Houston on the map as the world’s cardiovascular surgery capital. But their falling out over an artificial heart in 1969 created a rift that scandalized the medical community and raised profound questions about ambition, credit, and the price of genius.
The Mentor and the Prodigy
The story begins not with rivalry, but with collaboration. Michael DeBakey arrived at Baylor College of Medicine in Houston (the same training grounds Dr. Nathan Starke would use nearly 60 years later) in 1948, already a respected vascular surgeon with wartime experience. Born in 1908 to Lebanese immigrants in Lake Charles, Louisiana, DeBakey possessed an engineer’s precision and an entrepreneur’s ambition. He didn’t just want to be a good surgeon—he wanted to build an empire of cardiovascular excellence.
Denton Cooley came to Houston in 1951, joining DeBakey at Baylor after training at Johns Hopkins. Born in 1920 to a prominent Houston family, Cooley was tall, elegant, and possessed hands that seemed to move with supernatural speed and precision. Where DeBakey was intense and detail-oriented, Cooley was calm and efficient. Where DeBakey could take hours on a complex procedure, Cooley moved through operations with balletic grace, sometimes completing in 90 minutes what took others five hours.
For nearly a decade, they worked together brilliantly. DeBakey was the innovator and empire-builder; Cooley was the technical perfectionist who could execute DeBakey’s vision with unmatched skill. Operating side by side, they pioneered techniques for repairing aortic aneurysms, developed new approaches to coronary artery disease, and trained a generation of cardiac surgeons. Patients came from around the world to be treated by either man.
But beneath the surface, tension simmered. Cooley grew frustrated playing second fiddle to DeBakey, whose ego and need for control were legendary. DeBakey, meanwhile, bristled at Cooley’s growing reputation and independent streak.
The Split
In 1962, Cooley made his move. He left Baylor and DeBakey’s orbit to become chief of cardiovascular surgery at Texas Heart Institute, affiliated with St. Luke’s Hospital—just blocks away from DeBakey’s base at Methodist Hospital. The professional divorce was amicable enough on the surface, but the stage was set for competition.
What followed was an extraordinary period of surgical innovation driven by rivalry. Both men pushed themselves and their teams relentlessly. They competed for the most challenging cases, the most innovative procedures, and the brightest trainees. Young surgeons had to choose sides—you were either a DeBakey disciple or a Cooley acolyte.
DeBakey performed the first successful coronary artery bypass using a patient’s own vein in 1964—a procedure that would become one of the most common operations in medicine. Cooley countered with the first successful heart transplant in the United States in 1968, just months after Christiaan Barnard’s pioneering transplant in South Africa. Cooley’s patient, a 47-year-old accountant, survived for 204 days—far longer than most early transplant recipients.
The competition was fierce but largely professional. Both men elevated Houston’s profile, attracted funding and talent, and pushed each other to new heights. The Texas Medical Center benefited enormously from having two competing giants rather than one monopoly.
Then came 1969, and everything changed.
The Artificial Heart Controversy
The event that transformed competitive colleagues into bitter enemies involved a device, a dying patient, and questions about who deserved credit for what.
For years, DeBakey had been working with Dr. Domingo Liotta, a surgeon and engineer, to develop an artificial heart. The device was experimental, untested in humans, and not ready for clinical use—at least in DeBakey’s careful, methodical view. But Liotta was frustrated by the pace and began talking with Cooley, who had a very different philosophy: when patients were dying anyway, bold action was justified.
On April 4, 1969, Cooley performed a procedure that shocked the medical world. Haskell Karp, a 47-year-old man dying of heart failure, received an artificial heart—a device implanted in his chest to keep him alive while waiting for a donor heart. It was the first time a mechanical heart had been used in a human being.
Cooley used a device developed by Liotta—the same Liotta who had been working in DeBakey’s lab. The operation made international headlines. For 64 hours, Karp lived with a mechanical heart pumping in his chest. When a donor heart became available, Cooley transplanted it. Karp died 32 hours later from pneumonia and kidney failure, but Cooley had proven the concept could work.
DeBakey was furious. He believed Cooley had stolen his research, jumped the line on an unproven device, and conducted what amounted to a reckless human experiment. Cooley maintained that he had used a modified version of Liotta’s design, that the patient was dying anyway, and that desperate situations called for bold measures. Liotta, caught in the middle, eventually left Houston for Spain.
The Fallout
The controversy exploded beyond Houston. The National Heart Institute investigated. Medical ethics committees debated. DeBakey called Cooley’s judgment into question. Cooley resigned from Baylor’s faculty, though he maintained his position at Texas Heart Institute.
But the deepest wound was personal. Two men who had once worked side by side, who had elevated Houston to global prominence in cardiovascular surgery, stopped speaking entirely. They attended the same conferences, worked blocks apart, trained surgeons who crossed paths constantly—but maintained absolute silence toward each other.
The feud became legendary in medical circles. Residents learned quickly never to mention one surgeon in the other’s operating room. The Texas Medical Center developed an invisible Berlin Wall, with Methodist Hospital and Texas Heart Institute representing two armed camps.
Yet remarkably, both men continued to excel. DeBakey continued his methodical innovations, performed over 60,000 operations in his career, and built Methodist Hospital into a cardiovascular powerhouse. He developed the ventricular assist device, pioneered telemedicine, and advised presidents and royalty. He operated well into his 90s.
Cooley, meanwhile, performed more than 118,000 heart operations—more than any surgeon in history. He refined techniques that made open-heart surgery safer and more routine. His speed and efficiency set standards that surgeons still try to match. Texas Heart Institute became one of the world’s premier cardiac centers, performing thousands of procedures annually.
The Rivalry’s Silver Lining
Here’s the remarkable thing: their feud may have been the best thing that could have happened to Houston—and to cardiac surgery.
Having two world-class cardiac surgery programs competing blocks apart created an unprecedented concentration of talent, resources, and innovation. Surgeons trained at both institutions, learning different philosophies and techniques. Pharmaceutical companies and medical device manufacturers invested heavily in Houston, knowing both programs would push the envelope. Patients benefited from having options and from the relentless drive for improvement that competition demanded.
The artificial heart controversy, despite its bitter aftermath, accelerated research into mechanical circulatory support. Today’s ventricular assist devices and total artificial hearts descend directly from that controversial 1969 operation. Thousands of patients now live with mechanical pumps keeping them alive—vindication for both men’s visions, even if they disagreed on timing and approach.
Medical historians argue about whether the rivalry helped or hurt cardiovascular surgery. The truth is probably both. The personal animosity was ugly and created an uncomfortable atmosphere for those caught between the two giants. But the competitive drive pushed both men to greater heights than either might have reached alone.
The Reconciliation
For 40 years, the silence held. Colleagues tried to broker peace; both men refused. They aged—DeBakey into his 90s, Cooley into his 80s—but the grudge remained.
Then, in November 2007, something remarkable happened. At a gala celebrating Baylor College of Medicine’s 60th anniversary, the two elderly surgeons were both honored. DeBakey was 99; Cooley was 87. In front of hundreds of colleagues and former students, they shook hands and embraced.
“It’s water under the bridge,” Cooley said simply. The room erupted in applause. Surgeons who had lived through the feud, who had carefully navigated the divide for decades, witnessed two legends burying the hatchet.
DeBakey died eight months later, at age 99, having never fully retired from surgery. Cooley continued operating into his 80s and remained active at Texas Heart Institute until his death in 2016 at age 96.
The Legacy
Walk through the Texas Medical Center today, and you’ll see the legacy of the DeBakey-Cooley rivalry everywhere. Methodist Hospital and Texas Heart Institute still stand blocks apart, both excellent, both busy, both continuing to push boundaries in cardiac care. The competition mellowed after the principals died, but the drive for excellence they instilled remains.
Thousands of surgeons trained under one or both men, carrying their techniques and philosophies to hospitals worldwide. The procedures they pioneered—coronary bypass, heart transplants, mechanical circulatory support—have saved millions of lives. Houston’s reputation as a cardiovascular surgery destination traces directly to their work and their rivalry.
The artificial heart controversy raised ethical questions that remain relevant: When is it appropriate to try an untested procedure? How do you balance innovation against patient safety? Who deserves credit when multiple people contribute to a breakthrough? These aren’t easy questions, and the DeBakey-Cooley feud didn’t resolve them. But their story illustrates the tensions inherent in cutting-edge medicine.
Perhaps most importantly, their rivalry demonstrated that competition in medicine—when channeled properly—can drive extraordinary progress. The personal animosity was unfortunate, even petty at times. But the surgical innovations, the lives saved, the surgeons trained, and the institutions built represent an achievement that transcended personal conflict.
The Human Element
It’s easy to focus on the feud and forget that both men were, in their own ways, trying to save lives under impossible circumstances. Heart surgery in the 1960s was barely beyond experimental. Patients came to Houston because they’d been told nothing could be done. DeBakey and Cooley were operating on people who would otherwise die, trying techniques that had never been attempted, making decisions in real-time with lives hanging in the balance.
DeBakey’s caution came from a deep sense of responsibility and a scientist’s rigor. He wanted proof before proceeding. Cooley’s boldness came from a surgeon’s confidence and a willingness to take calculated risks when patients had no other options. Both approaches had merit; both saved lives; both sometimes failed.
The tragedy is that two men who shared so much—a passion for cardiac surgery, a commitment to Houston, a desire to push medical boundaries—couldn’t reconcile their differences for four decades. The blessing is that their competition pushed them both to heights neither might have reached without the other as a foil.
Conclusion
The DeBakey-Cooley rivalry is ultimately a very human story about ego, ambition, innovation, and redemption. It’s about what drives people to excellence and what price they pay for it. It’s about how competition can fuel progress even when personal relationships fracture.
Houston became the heart surgery capital of the world not despite having two feuding surgical giants, but in some ways because of it. The concentration of talent, the drive to be better than the guy down the street, the patients who came seeking the best—all of it combined to create something extraordinary.
The handshake in 2007 didn’t erase 40 years of silence. But it acknowledged something both men had always known but couldn’t quite admit: they had needed each other. The rivalry that defined their careers and shaped Houston’s medical destiny was, in the end, a partnership of sorts—adversarial, uncomfortable, but ultimately productive.
Today, when cardiac surgeons at Methodist Hospital and Texas Heart Institute collaborate on complex cases, when they share research and cross-train residents, they’re building on a foundation laid by two men who couldn’t stand to be in the same room together but who together changed the world.
That’s the paradox and the power of the DeBakey-Cooley rivalry: it was petty and profound, destructive and creative, a cautionary tale and an inspiration. It’s a reminder that medical progress rarely follows a straight path, that genius can be difficult, and that sometimes the greatest achievements emerge from the most unlikely circumstances—even a feud between two surgeons who refused to speak but never stopped competing to save lives.